Us Fda
Recent Highlights
All Stories for Us Fda
America is breathing heavy: Why the shortage of medicine to treat asthma, chronic bronchitis is worsening
Fp Explainers •The US is already facing a shortage of liquid albuterol used to treat patients with respiratory illnesses like asthma, COPD, chronic bronchitis and acute COVID-19. With a major supplier of the drug to US hospitals shutting down and allergy season around the corner, doctors have all reasons to worry
COVID-19: US approves updated Pfizer, Moderna shots targeting new strains of Omicron
•This new generation of vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States
US regulator FDA authorises Merck's COVID-19 pill for high risk adults
•The FDA has not authorized Merck's pill for people under 18 because it may affect bone and cartilage growth.
US gives final clearance to Pfizer's COVID-19 vaccine shot for children between 5 to 11 years
•The decision marks the first opportunity for Americans under 12 to get the powerful protection of any COVID-19 vaccine
FDA panel endorses Pfizer’s low-dose COVID-19 vaccine for children aged 5 to 11 years
•A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks
Pfizer-BioNtech submit data to health authorities for approval of third COVID-19 vaccine
•The companies plan to submit the same information to European authorities in the coming weeks.
US FDA rejects emergency use authorisation for Bharat Biotech's COVID-19 jab Covaxin; all you need to know
Ananyas •Covaxin had earlier suffered a similar impediment in securing World Health Organisation approvals after the world body said it needed more research data before it can grant the EUL
Moderna's COVID-19 vaccine 'strongly protects' kids in 12-17 age group, says pharma company
•The company studied more than 3,700 12- to 17-year-olds. Preliminary findings showed the vaccine triggered the same signs of immune protection in kids as it does in adults, and the same kind of temporary side effects such as sore arms, headache, and fatigue
From supply chains to vaccines, China has frequently thrown spanner into works of India's COVID-19 battle
Fp Staff •From tactfully disallowing Chinese firms to participate in BMC's global vaccine tender to exorbitant pricing of necessary equipment, India's battle against COVID-19 has often run into rough weather with China
COVID-19: Pfizer-BioNTech vaccine 100% effective in 12 to 15-year-olds, say companies
•Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses", the companies said in a statement